RXL ETF Price & Analysis
RXL ETF Chart & Stats
47.47
--
Market closed
47.47
--
Day’s Range― - ―
52-Week Range36.23 - 55.58
Previous Close47.47
VolumeN/A
Average Volume (3M)11.04K
AUM75.56M
NAV47.67
Expense Ratio0.95%
Holdings Count60
Beta1.01
Inception DateJan 30, 2007
Last Dividend Ex-Date
Mar 25, 2026Dividend Yield
(1.58%)Shares OutstandingN/A
Standard DeviationN/A
10 Day Avg. Volume9,525
30 Day Avg. Volume11,037
AlphaN/A
ETF Overview
ProShares Ultra Health Care
ProShares Ultra Health Care (RXL) is an exchange-traded fund meticulously designed for those looking to capitalize on the dynamic opportunities within the health care sector. As a sector-focused ETF, RXL stands out by offering investors amplified exposure to the robust and ever-evolving health care industry. This fund seeks to provide twice the daily performance of the Dow Jones U.S. Health Care Index, allowing investors to leverage their investments to potentially achieve higher returns.
In a broad-based niche, ProShares Ultra Health Care covers a comprehensive range of health care sub-sectors, including pharmaceuticals, biotechnology, medical devices, and health care providers. This diversified yet concentrated approach makes RXL an attractive option for investors aiming to harness the growth potential from innovations and advancements in medical technology and health care services.
Whether you're looking to hedge existing health care positions or seeking a tactical investment to capitalize on short-term movements within the sector, RXL offers a compelling and efficient solution. With its focus on delivering leveraged exposure to health care, this ETF is tailored for investors with a strong conviction in the sector's growth trajectory and a higher risk tolerance.
ProShares Ultra Health Care (RXL) Fund Flow Chart
ProShares Ultra Health Care (RXL) 1 year Net Flows: -1M
RXL ETF News
RXL ETF FAQ
What was RXL’s price range in the past 12 months?
RXL lowest ETF price was 36.23 and its highest was 55.58 in the past 12 months.
What is the AUM of RXL?
As of Apr 08, 2026 The AUM of RXL is 75.56M.
Is RXL overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does RXL pay dividends?
RXL pays a Quarterly dividend of 0.144 which represents an annual dividend yield of 1.58%. See more information on RXL dividends here
How many shares outstanding does RXL have?
Currently, no data Available
Which hedge fund is a major shareholder of RXL?
Currently, no hedge funds are holding shares in RXL
Top 10 Holdings
Eli Lilly And Company
11.00%
U.S. Dollar
10.83%
ProShares GENIUS Money Market ETF
10.82%
Johnson & Johnson
8.46%
Abbvie
5.44%
Merck & Company
4.45%
Unitedhealth Group Inc.
4.04%
Thermo Fisher Scientific
2.75%
Amgen Inc
2.74%
Abbott Laboratories
2.62%
Total63.20%
See All Holdings


